CRA Insights

Balancing the opportunities and challenges of developing companion diagnostics: Part 2 of 2

June 4, 2014

In this article we discuss the challenges for manufacturers of therapeutics and diagnostics as they pursue the potential of companion diagnostics. Click below to read the article.

Download

Related Capabilities

Life Sciences

Matthew Majewski
Vice President

New York
+1-212-520-7260 mmajewski@crai.com

Intellectual Property
CRA Insights

IP Insights: Notable developments in IP litigation: April 2021

Sprint Communications Company LP v. WideOpenWest, Inc. et al., Case No. 1-18-cv-00361 (US District Court of Delaware) Sprint Communications filed lawsuits...
Life Sciences
Reports

Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers’ perspective: a two-part study

The 32-item Motor Function Measure (MFM32) is a clinician-reported outcome measure used to assess the functional abilities of individuals with neuromuscular...

Explore our thinking

See all events

Balancing the opportunities and challenges of developing companion diagnostics: Part 2 of 2

Meet the authors

Related Insights

IP Insights: Notable developments in IP litigation: April 2021

Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers’ perspective: a two-part study

Upcoming Events

The Leukemia & Lymphoma Society’s 2021 New England Man & Woman of the Year

HTAi 2021 Annual Meeting Manchester: Innovation Through HTA